AEM1 decreased Nrf2 target gene transcription and acted synergistically with ROS-producing chemotherapy, although AEM1 treatment alone reduced tumor growth in vivo compared to control-treated mice [85]. The gene discussed is NFE2L2; the disease is neoplasm.